Inclusion Criteria:

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Diagnosis of epilepsy
• At least 2 years since participants most recent seizure
• At most 35% calculated 1-year post-discontinuation seizure risk, based upon the existing multivariable calculator if they are on only 1 ASM, otherwise no such restriction if they are more than 1 ASM
• Willingness to adhere to the study intervention
• Taking at least 1 antiseizure medication prior to enrollment

Exclusion Criteria:

• Current pregnancy or planned pregnancy during the study period
• History of epilepsy surgery
• Large space-occupying radiographic lesion such as a large cortical tumor, large artery stroke, or encephalomalacia from traumatic brain injury.
• Subject has any other clinically significant conditions or circumstances that in the judgment of the investigator or treating clinician should preclude study participation.

Please note: The researchers will ask participants not to drive for 2 months after ASM discontinuation if on monotherapy, and exercise caution while driving if stopping one antiseizure medication but remaining on others